Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)
Guardat en:
| Autor principal: | |
|---|---|
| Altres autors: | |
| Format: | Journal Article |
| Idioma: | anglès |
| Matèries: | |
| Accés en línia: | DOI Path |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Ítems similars: Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)
- Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)
- The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy
- PHARMACOTHERAPIES TO ENHANCE SMOKING CESSATION DURING PREGNANCY
- AN ALGORITHM FOR TAILORING PHARMACOTHERAPY FOR SMOKING CESSATION: RESULTS FROM A DELPHI PANEL OF INTERNATIONAL EXPERTS
- USE OF NICOTINE REPLACEMENT HTERAPY TO REDUCE OR DELAY SMOKING BUT NOT TO QUIT: PREVALENCE AND ASSOCIATION WITH SUBSEQUENT CESSATION EFFORTS
- ASSOCIATION OF CYP2D6 ULTRARAPID METABOLIZER GENOTYPE WITH DEFICIENT PATIENT SATISFACTION REGARDING METHADONE MAINTENANCE TRATMENT